Varenicline for Cognitive Deficits and Cigarette Smoking in Schizophrenia - Efficacy and Predictors

Clinical trial NCT00802919 · COMPLETED

Trial details

NCT number: NCT00802919
Sponsor: Nathan Kline Institute for Psychiatric Research
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Schizophrenia Cigarette Smoking

Start date: 2008-09-01
Primary completion: 2013-12-01
Enrollment: 93

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.